Scientific publications

Twists and turns to translating 4-1BB cancer immunotherapy

Jun 12, 2019 | Magazine: Science Translational Medicine

Miguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, Ignacio Melero


Previous shortcomings of CD137-targeted immunotherapy may be overcome by engineered bispecific agents (Claus et al, this issue).

CITATION  Sci Transl Med. 2019 Jun 12;11(496):eaax4738. doi: 10.1126/scitranslmed.aax4738.